Cargando…

A streamlined pipeline for multiplexed quantitative site-specific N-glycoproteomics

Regulation of protein N-glycosylation is essential in human cells. However, large-scale, accurate, and site-specific quantification of glycosylation is still technically challenging. We here introduce SugarQuant, an integrated mass spectrometry-based pipeline comprising protein aggregation capture (...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Pan, Ji, Yanlong, Silbern, Ivan, Doebele, Carmen, Ninov, Momchil, Lenz, Christof, Oellerich, Thomas, Pan, Kuan-Ting, Urlaub, Henning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572468/
https://www.ncbi.nlm.nih.gov/pubmed/33077710
http://dx.doi.org/10.1038/s41467-020-19052-w
_version_ 1783597342649221120
author Fang, Pan
Ji, Yanlong
Silbern, Ivan
Doebele, Carmen
Ninov, Momchil
Lenz, Christof
Oellerich, Thomas
Pan, Kuan-Ting
Urlaub, Henning
author_facet Fang, Pan
Ji, Yanlong
Silbern, Ivan
Doebele, Carmen
Ninov, Momchil
Lenz, Christof
Oellerich, Thomas
Pan, Kuan-Ting
Urlaub, Henning
author_sort Fang, Pan
collection PubMed
description Regulation of protein N-glycosylation is essential in human cells. However, large-scale, accurate, and site-specific quantification of glycosylation is still technically challenging. We here introduce SugarQuant, an integrated mass spectrometry-based pipeline comprising protein aggregation capture (PAC)-based sample preparation, multi-notch MS3 acquisition (Glyco-SPS-MS3) and a data-processing tool (GlycoBinder) that enables confident identification and quantification of intact glycopeptides in complex biological samples. PAC significantly reduces sample-handling time without compromising sensitivity. Glyco-SPS-MS3 combines high-resolution MS2 and MS3 scans, resulting in enhanced reporter signals of isobaric mass tags, improved detection of N-glycopeptide fragments, and lowered interference in multiplexed quantification. GlycoBinder enables streamlined processing of Glyco-SPS-MS3 data, followed by a two-step database search, which increases the identification rates of glycopeptides by 22% compared with conventional strategies. We apply SugarQuant to identify and quantify more than 5,000 unique glycoforms in Burkitt’s lymphoma cells, and determine site-specific glycosylation changes that occurred upon inhibition of fucosylation at high confidence.
format Online
Article
Text
id pubmed-7572468
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-75724682020-10-21 A streamlined pipeline for multiplexed quantitative site-specific N-glycoproteomics Fang, Pan Ji, Yanlong Silbern, Ivan Doebele, Carmen Ninov, Momchil Lenz, Christof Oellerich, Thomas Pan, Kuan-Ting Urlaub, Henning Nat Commun Article Regulation of protein N-glycosylation is essential in human cells. However, large-scale, accurate, and site-specific quantification of glycosylation is still technically challenging. We here introduce SugarQuant, an integrated mass spectrometry-based pipeline comprising protein aggregation capture (PAC)-based sample preparation, multi-notch MS3 acquisition (Glyco-SPS-MS3) and a data-processing tool (GlycoBinder) that enables confident identification and quantification of intact glycopeptides in complex biological samples. PAC significantly reduces sample-handling time without compromising sensitivity. Glyco-SPS-MS3 combines high-resolution MS2 and MS3 scans, resulting in enhanced reporter signals of isobaric mass tags, improved detection of N-glycopeptide fragments, and lowered interference in multiplexed quantification. GlycoBinder enables streamlined processing of Glyco-SPS-MS3 data, followed by a two-step database search, which increases the identification rates of glycopeptides by 22% compared with conventional strategies. We apply SugarQuant to identify and quantify more than 5,000 unique glycoforms in Burkitt’s lymphoma cells, and determine site-specific glycosylation changes that occurred upon inhibition of fucosylation at high confidence. Nature Publishing Group UK 2020-10-19 /pmc/articles/PMC7572468/ /pubmed/33077710 http://dx.doi.org/10.1038/s41467-020-19052-w Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Fang, Pan
Ji, Yanlong
Silbern, Ivan
Doebele, Carmen
Ninov, Momchil
Lenz, Christof
Oellerich, Thomas
Pan, Kuan-Ting
Urlaub, Henning
A streamlined pipeline for multiplexed quantitative site-specific N-glycoproteomics
title A streamlined pipeline for multiplexed quantitative site-specific N-glycoproteomics
title_full A streamlined pipeline for multiplexed quantitative site-specific N-glycoproteomics
title_fullStr A streamlined pipeline for multiplexed quantitative site-specific N-glycoproteomics
title_full_unstemmed A streamlined pipeline for multiplexed quantitative site-specific N-glycoproteomics
title_short A streamlined pipeline for multiplexed quantitative site-specific N-glycoproteomics
title_sort streamlined pipeline for multiplexed quantitative site-specific n-glycoproteomics
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572468/
https://www.ncbi.nlm.nih.gov/pubmed/33077710
http://dx.doi.org/10.1038/s41467-020-19052-w
work_keys_str_mv AT fangpan astreamlinedpipelineformultiplexedquantitativesitespecificnglycoproteomics
AT jiyanlong astreamlinedpipelineformultiplexedquantitativesitespecificnglycoproteomics
AT silbernivan astreamlinedpipelineformultiplexedquantitativesitespecificnglycoproteomics
AT doebelecarmen astreamlinedpipelineformultiplexedquantitativesitespecificnglycoproteomics
AT ninovmomchil astreamlinedpipelineformultiplexedquantitativesitespecificnglycoproteomics
AT lenzchristof astreamlinedpipelineformultiplexedquantitativesitespecificnglycoproteomics
AT oellerichthomas astreamlinedpipelineformultiplexedquantitativesitespecificnglycoproteomics
AT pankuanting astreamlinedpipelineformultiplexedquantitativesitespecificnglycoproteomics
AT urlaubhenning astreamlinedpipelineformultiplexedquantitativesitespecificnglycoproteomics
AT fangpan streamlinedpipelineformultiplexedquantitativesitespecificnglycoproteomics
AT jiyanlong streamlinedpipelineformultiplexedquantitativesitespecificnglycoproteomics
AT silbernivan streamlinedpipelineformultiplexedquantitativesitespecificnglycoproteomics
AT doebelecarmen streamlinedpipelineformultiplexedquantitativesitespecificnglycoproteomics
AT ninovmomchil streamlinedpipelineformultiplexedquantitativesitespecificnglycoproteomics
AT lenzchristof streamlinedpipelineformultiplexedquantitativesitespecificnglycoproteomics
AT oellerichthomas streamlinedpipelineformultiplexedquantitativesitespecificnglycoproteomics
AT pankuanting streamlinedpipelineformultiplexedquantitativesitespecificnglycoproteomics
AT urlaubhenning streamlinedpipelineformultiplexedquantitativesitespecificnglycoproteomics